Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advanced Cancer Therapeutics, LLC
Advanced Cancer Therapeutics Appoints Gilles Tapolsky, Ph.D. to Chief Scientific Officer
September 5th, 2008
Advanced Cancer Therapeutics, LLC (ACT) announced that industry veteran Gilles H. Tapolsky, Ph.D. has joined ACT as chief scientific officer. Dr. Tapolsky brings over 20 years of experience in corporate management, research and pharmaceutical development to ACT. In this newly created position, he will be responsible for the leadership of all pre-clinical and clinical development activities. "We are thrilled to have Gilles join our team. He has led a distinguished career in pharmaceutical development and is recognized as a leader in the biotechnology field," said Randall B. Riggs, president & chief executive officer at ACT. "With his track record of...
Source: Health Business Week (2008-09-05)
|
